Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New systematically active antimycotics from the beta-blocker category

H Hänel1, R Kirsch, H L Schmidts

  • 1Hoechst AG, Frankfurt/Main, Germany.

Mycoses
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Correction to: Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2020
Same author

Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2019
Same author

Editorial: validating reliability of the eosinophilic oesophagitis histological scoring system (EOE-HSS)-an important first step.

Alimentary pharmacology & therapeutics·2018
Same author

Whipple's Disease in an Afro-Caribbean National.

The West Indian medical journal·2014

New beta-blocker-like compounds show significant antifungal activity against Candida albicans. These novel antimycotics effectively inhibit fungal cell penetration and protect mice in vivo.

Area of Science:

  • Mycology
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Candida albicans secretes phospholipases, crucial for fungal cell penetration.
  • Lipophilic beta-blocking structures are known inhibitors of mammalian phospholipases.

Purpose of the Study:

  • To synthesize and evaluate novel beta-hydroxyethylamine derivatives as potential antimycotics.
  • To assess the in vitro and in vivo efficacy of these compounds against Candida albicans.

Main Methods:

  • Synthesis of beta-hydroxyethylamine derivatives.
  • In vitro antifungal assays against Candida albicans.
  • In vivo studies using a murine model of invasive candidiasis.
  • Histological examination of tissue penetration.

Related Experiment Videos

Main Results:

  • Several synthesized compounds demonstrated broad in vitro antifungal activity.
  • In combination with fluconazole, these compounds significantly reduced mortality in infected mice.
  • Histological analysis confirmed inhibition of fungal tissue penetration by the novel compounds.

Conclusions:

  • Beta-blocker-like structures derived from beta-hydroxyethylamines represent a new class of antimycotics.
  • These compounds exhibit potent in vitro and in vivo efficacy against Candida albicans.
  • They effectively inhibit fungal cell penetration, offering a promising therapeutic strategy.